Join to View Full Profile
1145 Olentangy River RdColumbus, OH 43212
Phone+1 614-293-0066
Fax+1 614-293-7264
Dr. Stover is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2012 - 2015
Vanderbilt University Medical CenterResidency, Internal Medicine, 2008 - 2012
Vanderbilt University School of MedicineClass of 2008
Certifications & Licensure
OH State Medical License 2017 - 2026
MA State Medical License 2012 - 2019
TN State Medical License 2010 - 2013
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Sulfatase 2 inhibition sensitizes triple-negative breast cancer cells to paclitaxel through augmentation of extracellular ATP.Jasmine M Manouchehri, Jharna Datta, Lynn M Marcho, Daniel Stover, Ramesh K Ganju
Cancer Biology & Therapy. 2025-12-01 - The breast tumor immune microenvironment of DNA double-strand break repair pathogenic variant carriers is enriched with tumor-associated macrophages.Rebecca L Kelly, Yuxi Liu, Alexandra R Harris, Cheng Peng, Yujing J Heng
Cancer Epidemiology, Biomarkers & Prevention. 2025-04-02 - 1 citationsAdjuvant Dose-Dense Chemotherapy in Hormone Receptor-Positive Breast Cancer.Otto Metzger Filho, Karla Ballman, Jordan Campbell, Minetta Liu, Jennifer Ligibel
Journal of Clinical Oncology. 2025-04-01
Journal Articles
- Tumor Fraction in Cell-Free DNA as a Biomarker in Prostate CancerHeather A. Parsons, Atish D. Choudhury, Lauren C. Harshman, Daniel G. Stover, The Journal of Clinical Investigation
Press Mentions
New Hormonal Treatment Orserdu Approved for Metastatic Breast CancerFebruary 13th, 2023- Twitter: Dr Toni Choueiri – FDA Approve Pembrolizumab Top Tweet Q4 2021November 4th, 2021
- De-Escalation of Radiation Therapy in Patients with Stage I, Node-Negative, HER2-Positive Breast CancerMarch 25th, 2021
- Join now to see all
Grant Support
- Assay Validation of Cell-Free DNA Shallow Whole Genome Sequencing To Determine 'Tumor Fraction' in Advanced CancersBROAD INSTITUTE, INC.2022–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
